(PCRX) Pacira Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Pacira Pharmaceuticals | (PCRX) share price targets
Complete technical analysis of Pacira Pharmaceuticals (PCRX) by charts plus indicators, forecast predictions and share price targets for Pacira Pharmaceuticals (PCRX)
Pacira Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-04 View latest technical analysis
10 day averaged volume of Pacira Pharmaceuticals is 594156
| Date | Daily Closing Price | Open | High | Low | Volume |
| 04 Tue Jun 2024 | 30.52 | 30.86 | 30.99 | 30.15 | 1.482 times |
| 03 Mon Jun 2024 | 30.89 | 30.47 | 31.64 | 30.15 | 1.099 times |
| 31 Fri May 2024 | 30.33 | 30.68 | 30.99 | 30.21 | 1.207 times |
| 30 Thu May 2024 | 30.46 | 29.48 | 30.82 | 29.37 | 1.021 times |
| 29 Wed May 2024 | 29.26 | 29.74 | 29.74 | 28.91 | 0.982 times |
| 28 Tue May 2024 | 30.05 | 29.76 | 30.40 | 29.71 | 0.707 times |
| 23 Thu May 2024 | 30.32 | 30.72 | 30.83 | 30.05 | 0.641 times |
| 22 Wed May 2024 | 30.72 | 30.72 | 31.07 | 30.60 | 0.763 times |
| 21 Tue May 2024 | 30.90 | 30.56 | 31.27 | 30.23 | 1.63 times |
| 20 Mon May 2024 | 30.61 | 30.70 | 30.90 | 30.23 | 1.145 times |
My analysis of stock is bullish for shortterm, and stock might move up till 31.3 or till 32.8. Use a stoploss of 29.98 and if this stock hits its stoploss, then it can fall down till 28.71
Share price targets for Pacira Pharmaceuticals (PCRX)
| Target Type | Value |
| Downside Target | 25.33 |
| Downside Target | 26.27 |
| Downside Target | 27.37 |
| Downside Target | 28.91 |
| Upside Target | 30.99 |
| Upside Target | 31.27 |
| Upside Target | 31.47 |
| Upside Target | 31.64 |
| Upside Target | 31.67 |
| Upside Target | 32.65 |
Intraday share price targets for Pacira Pharmaceuticals (PCRX)
| Target Type | Value |
| Downside Intraday Target | 29.9 |
| Downside Intraday Target | 29.28 |
| Upside Intraday Target | 31.39 |
| Upside Intraday Target | 32.26 |
| Upside Intraday Target | 30.77 |
Weekly technical analysis of Pacira Pharmaceuticals (PCRX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 04 Tue Jun 2024 | 30.52 | 30.47 | 31.64 | 30.15 | 0.659 times |
| 31 Fri May 2024 | 30.33 | 29.76 | 30.99 | 28.91 | 0.937 times |
| 23 Thu May 2024 | 30.32 | 30.70 | 31.27 | 30.05 | 0.572 times |
| 17 Fri May 2024 | 30.82 | 29.79 | 31.67 | 29.79 | 0.38 times |
| 10 Fri May 2024 | 29.42 | 27.45 | 30.70 | 26.43 | 5.55 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Pacira Pharmaceuticals (PCRX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 04 Tue Jun 2024 | 30.52 | 30.47 | 31.64 | 30.15 | 0.071 times |
| 31 Fri May 2024 | 30.33 | 26.28 | 31.67 | 26.27 | 2.265 times |
| 30 Tue Apr 2024 | 26.25 | 29.44 | 29.47 | 25.33 | 0.936 times |
| 28 Thu Mar 2024 | 29.22 | 29.69 | 31.47 | 27.89 | 0.897 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Pacira Pharmaceuticals (PCRX)
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Pacira Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Pacira Pharmaceuticals in short term but the sell signal is initial and weak.
Pacira Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Pacira Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Pacira Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 30.45 and Pacira Pharmaceuticals (PCRX) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Pacira Pharmaceuticals (PCRX) stock. Volume based technical analysis of Pacira Pharmaceuticals (PCRX) stock is negative.
Pacira Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Pacira Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Pacira Pharmaceuticals in short term but the sell signal is initial and weak.
Pacira Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Pacira Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Pacira Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 30.45 and Pacira Pharmaceuticals (PCRX) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Pacira Pharmaceuticals (PCRX) stock. Volume based technical analysis of Pacira Pharmaceuticals (PCRX) stock is negative.
Pacira Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.